/
Biological products, (no diagnostic substances) company · DE · FY ends Dec · Revenue $5M · -4238.99% margin · -$160M FCF
The business is unprofitable at the operating level (-4722.13% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue up 254.7% YoY with margins expanding 5345.1pp.
Negative free cash flow of -$132M. The business is consuming cash, not generating it.
Profitability & Returns
Revenue (TTM)
$5M
▲ +254.7% YoY
Net Income (TTM)
-$187M
▼ -82.9% YoY
Op. Margin
-4238.99%
▲ +5345.1pp YoY
ROIC
-21.06%
▲ +4.5pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-$160M
▼ -67.8% YoY
Op. Cash Flow (TTM)
-$160M
▼ -68.1% YoY
Net Debt
-$1.07B
Net Cash Position
Cash & Equiv.
$1.08B
Continue Research